How oncRNA Technology Could Revolutionize Cancer Diagnostics
Exai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read MorePosted by Chris Wolski | Sep 2, 2022 | Cancer, Molecular Diagnostics |
Exai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read MorePosted by Tonya Manning | Sep 1, 2022 | Podcasts |
Of all the changes caused by the COVID-19 pandemic, the evolution of POC and home testing is perhaps the biggest. CLP Director of Business Intelligence Chris Wolski and Hamid Erfanian, CEO of Enzo Biochem, an integrated healthcare company focused on offering life sciences, including reagents, clinical testing and molecular diagnostic products, do a deep dive on the history of POC testing, how and why it became ubiquitous during COVID-19, and what this ubiquity means for the future of the clinical laboratory.
Read MorePosted by Andy Lundin | Sep 1, 2022 | Unknown Origin & Other Cancer Types |
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MorePosted by Andy Lundin | Aug 30, 2022 | Dementias & Alzheimer’s, Diagnostic Technologies |
Research shows how large-scale, sensor-based health monitoring can address age-related diseases and health problems that are discovered late.
Read MorePosted by Andy Lundin | Aug 30, 2022 | Covid 19 |
In a new development of SARS-COV-2 diagnostics, MRIGlobal helped design, develop, and validate a multiplex panel that detects COVID variants.
Read More